N-(5-芳苄叉基饶丹宁)左氧氟沙星酰胺的合成及抗肿瘤活性

为进一步发现氟喹诺酮药物向抗肿瘤活性转化的结构修饰新策略,用酰氨基为左氧氟沙星(1)C-3羧基的电子等排体,5-芳苄叉基饶丹宁为其功能修饰基,设计合成了N-(5-芳苄叉基饶丹宁)左氧氟沙星酰胺类目标化合物(6a-6n)。 体外抗肿瘤活性结果表明,所合成的14个化合物的活性均强于母体左氧氟沙星,且对正常细胞表现出较低的细胞毒性作用。 构效关系表明,增大芳基取代基的体积或供电性均导致抗肿瘤活性的明显降低,反之,吸电子取代苯基或芳香杂环类目标化合物的抗肿瘤活性强于其他取代基类。 其中,硝基化合物6l、呋喃6m和吡啶6n对人胰腺癌细胞株(Capan-1)的半数抑制浓度(IC₅₀) 与对照抗肿瘤药阿霉素(1.6 μmol/L)相当,分别为1.8、0.8和1.3 μmol/L。 因此,芳苄叉基饶丹宁修饰的酰氨基替代C-3羧基有利于提高氟喹诺酮的抗肿瘤活性。     

微波辐射下2-[4-二-(4-氟苯)甲基]哌嗪乙酰腙化合物的合成

微波辐射条件下, 以丙酮作溶剂, 1-[二-(4-氟苯)甲基]哌嗪与氯乙酸乙酯反应得到2-[二-(4-氟苯)甲基]哌嗪乙酸乙酯(1), 1与水合肼在微波辐射条件下反应得到2-[二-(4-氟苯)甲基]哌嗪乙酰肼(2), 进一步在微波辐射条件下由2-[二- (4-氟苯)甲基]哌嗪乙酰肼(2)与取代芳香醛反应制得目标化合物3a～3f. 合成的6个目标化合物通过熔点测定和质谱、红外光谱、核磁共振氢谱分析、元素分析对其结构进行确证.     

含哌嗪片段的噻吩查尔酮衍生物的合成及其抗菌活性

查尔酮是一类具有多种生物活性的1,3-二苯基丙烯酮化合物.以4-氟苯乙酮和2-噻吩甲醛为原料出发,经取代、Aldol反应和衍生化,合成得到16个未见文献报道的含哌嗪片段的噻吩查尔酮衍生物.以氧氟沙星、左氧氟沙星、莫西沙星作阳性对照,采用K-B纸片扩散法测试了目标化合物对金黄色葡萄球菌(Staphylococcus aureus Rosenbach)、大肠埃希菌(Escherichia coli)和枯草芽孢杆菌(Bacillus subtilis)的抑菌活性.结果表明,(E)-1-[4-(4-肉桂酸甲酯甲基哌嗪基)苯基]-3-(噻吩-2-基)丙-2-烯酮(4b)和(E)-1-{4-[4-(2-氧亚基苯乙基)哌嗪基]苯基}-3-(噻吩-2-基)丙-2-烯酮(4e)对枯草芽孢杆菌高度敏感,且最低抑菌浓度为4.0μg/m L.     

含氟8-羟基喹啉锌配合物的合成与发光性能

设计合成了2种含三氟甲基的8-羟基喹啉衍生物配体:(E)-2-[2-(3-三氟甲基苯基)乙烯基]-8-羟基喹啉(3a)、(E)-2-[2-(4-三氟甲基苯基)乙烯基]-8-羟基喹啉(3b)及其相应的锌配合物(4a)、(4b),并由1H NMR、IR、MS、元素分析确认了其结构。通过紫外滴定观察了金属锌与配体的配合过程,测定了它们在DMF溶液中的荧光性质;荧光光谱显示化合物3a、3b在DMF溶液中的λmax分别是491nm和513nm,4a、4b的λmax分别是585nm和599nm,而且改变三氟甲基的位置可以调节配合物的发光性能。     

离子液体型表面活性剂研究

以1-甲基咪唑为原料, 制备了6个常规离子液体: 1-正丁基-3-甲基咪唑四氟硼酸盐及六氟磷酸盐(简称[bmim][BF₄]及[bmim][PF₆])、1-正己基-3-甲基咪唑四氟硼酸盐及六氟磷酸盐(简称[hmim][BF₄]及[hmim][PF₆])、1-正十六烷基-3-甲基咪唑四氟硼酸盐及六氟磷酸盐(简称[C₁₆mim][BF₄]及[C₁₆mim][PF₆])和4个功能化离子液体: 1-(2-羟乙基)-3-甲基咪唑四氟硼酸盐及六氟磷酸盐(简称[2-hemim][BF₄]及[2-hemim][PF₆])、1-乙氧羰基甲基-3-甲基咪唑四氟硼酸盐及六氟磷酸盐(简称[eocmmim][BF₄]及[eocmmim][PF₆]). 研究了这两类离子液体的一些物理性能, 旨在挖掘离子液体在香料香精化妆品工业中的应用价值. 分别检测了它们与一般溶剂的互溶性, 并测定了它们的表面张力和发泡性能, 实验结果表明, 仅[C₁₆mim][BF₄]和[C₁₆mim][PF₆]具有发泡性能, 发泡力分别为68和120 mm.     

(E)-6-氯-2-(4-三氟甲基苯乙烯基)-3-喹啉甲酸的合成及其环化（英文）

设计了以6-氯-2-氯甲基-3-喹啉甲酸乙酯(1)为起始化合物与4-三氟甲基苯甲醛(2)通过"一锅法"反应合成(E)-6-氯-2-(4-三氟甲基苯乙烯基)-3-喹啉甲酸(3),化合物3在PPA的作用下发生傅瑞德尔-克拉夫茨酰基化反应得到2-氯-10-三氟甲基-12H-苯并[4,5]卓酮并[1,2-b]喹啉-12-酮(4)。所合成的化合物3,4未见文献报道,其结构经红外光谱、核磁共振氢谱、核磁共振碳谱和高分辨质谱得以证实。     

氟伐他汀钠的合成

以氟苯为起始原料,通过两步反应得N-(4-氟苯甲酰甲基)-N-(1-甲基乙基)苯胺(5);5在ZnCl2存在下环化得3-(4′-氟苯基)-1-(1′-甲基乙基)吲哚(6);6与3-N-甲基-N-苯基胺基丙烯醛发生Vilsmeier-Haauc反应得(E)-3-[3′-(4″-氟苯基)-1′-(1″-甲基乙基)吲哚-2′-基]-2-丙烯醛(8);8经缩合、还原、水解得氟伐他汀钠,总收率10.5%.     

新型含氮杂环硼-二吡咯亚甲基染料类荧光化合物的合成

以对羟基苯甲醛和2,4-二甲基吡咯为原料,设计并合成了两个新型的8-位苯系取代的硼-二吡咯亚甲基染料类荧光化合物--4,4-二氟-8-[4′-(3-吗啉丙氧基)苯基]-1,3,5,7-四甲基-4-硼-3a,4a-二氮杂-s-引达省和1,4-二{4,4-二氟-8-[4′-(2-乙氧基)苯基]-1,3,5,7-四甲基-4-...     

瑞戈非尼合成工艺研究

4-氨基-3-氟苯酚（2）和4-氯-N-甲基吡啶-2-甲酰胺（3）经亲核取代反应制得4-(4-氨基-3-氟苯氧基)-N-甲基吡啶-2-甲酰胺（4）; 4与4-氯-3-三氟甲基异氰酸苯酯（5）缩合得4-[4-[[[4-氯-3-(三氟甲基)苯基]氨甲酰基]氨基]-3-氟苯氧基]-N-甲基吡啶-2-甲酰胺（6）;6再用丙酮/水重结晶制得瑞戈非尼（1）,其结构经¹H NMR、 ¹³C NMR、 MS（ESI）和元素分析确证,晶型与原研一致。按优化后的合成工艺进行公斤级规模放大,产品总收率48.5%（以3计）,纯度99.86%。      

2-叔丁基-4-氟-苯并氧杂卓并[3,4-b]喹啉并[9,11]二氧戊环-14（6H）-酮的合成

以2-溴甲基-6,7-亚甲二氧基-3-喹啉酸乙酯(1)为原料,经三步合成了2-叔丁基-4-氟-苯并氧杂卓并[3,4-b]喹啉并[9,11]二氧戊环-14(6H)-酮(4)。其中,6-(2-氟-4-叔丁基-苯氧甲基)-[1,3]二氧戊环并[4,5-g]喹啉-7-羧酸是经一锅法合成的。它的分子内闭环反应是在Eaton’s reagent(P2O5-CH3SO3H)的作用下,在较温和的条件下进行的。所得新化合物3和4的结构经IR1、H NMR和元素分析得以证实。     

左氧氟沙星的噻唑并均三唑衍生物的合成及抗肿瘤活性

为进一步发展抗菌药氟喹诺酮向抗肿瘤活性转化的有效结构修饰策略,基于药效团骨架的迁越药物设计原理,用噻唑并均三唑稠环取代左氧氟沙星(1)C-3羧基的等排体,α,β-不饱和酮为其修饰基,设计合成了C-3噻唑并均三唑稠杂环目标化合物(6a-6l)。 体外抗肿瘤活性结构表明,所合成的12个化合物的活性均强于母体左氧氟沙星,化合物6e、6i、6j的活性与对照抗肿瘤药阿霉素相当。 因此,α,β-不饱和酮修饰的均三唑骨架替代C-3羧基有利于提高氟喹诺酮的抗肿瘤活性。     

左氧氟沙星3-芳苄叉基-喹啉-4-酮衍生物的合成及抗肿瘤活性

为进一步发现提高氟喹诺酮抗肿瘤活性的有效结构修饰策略,基于片段药物设计原理,通过喹啉-4(1H)-酮与芳香醛缩合反应合成了(S)-6-氟-7-(4-甲基-哌嗪-基)-8,1-(1,3-氧丙基)-3-芳苄叉基-2,3-二氢-喹啉-4(1H)-酮(3a-3l)目标化合物。 体外抗肿瘤活性结果表明,所合成的12个新化合物的活性均强于母体左氧氟沙星,其中F、Cl、Br取代的卤苯基化合物对人肝癌细胞株(SMMC-7721)和人胰腺癌细胞株(Capan-1)的半数抑制浓度(IC₅₀)低于其它取代基化合物,尤其是氯苯基化合物(3k)与对照抗肿瘤药阿霉素活性相当。 为此,芳苄叉基替代C-3羧基构建的3-芳苄叉基-喹啉-4-酮化合物有助于提高氟喹诺酮的抗肿瘤活性,提示α,β-不饱和酮片段作为一个有发展前景的氟喹诺酮的候选修饰基团值得进一步发展。     

氟喹诺酮C-3均三唑硫醚酮缩氨基硫脲衍生物的合成及抗肿瘤活性

为发现氟喹诺酮由抗菌活性向抗肿瘤活性转化的结构修饰方法,基于生物电子等排药物设计原理,用唑杂环作为氧氟沙星(1)C-3羧基的等排体、硫醚酮缩氨基硫脲为其功能侧链修饰基,设计合成C-3均三唑硫醚酮缩氨基硫脲目标化合物(6a~6g),其结构经元素分析和光谱数据确证。 体外抗肿瘤活性结果表明,中间体C-3均三唑硫醚酮(5a~5g)和目标化合物(6a~6g)的活性均强于母体氧氟沙星的活性,其中缩氨基硫脲的活性强于相应硫醚酮的活性,尤其是苯环含硝基和氟原子目标化合物的活性与对照药阿霉素的活性相当。 因此,功能缩氨基硫脲链修饰的均三唑作为C-3羧基的等排体有利于提高氟喹诺酮的抗肿瘤活性。     

CoMFA Study on Anti-proliferative Activity of Fluoroquinolone Amide Derivatives

The in vitro anti-proliferative activity （pICi,i=hp,ca,hl） of fluoroquinolone （rhodanineα,β-unsaturated ketone）amide compounds,referred to as“fluoroquinolone amide derivatives （FQADs）”towards Hep-3B,Capan-1 and HL60 cells,was studied by the 3D-QSAR method of comparative molecular field analysis （Co MFA）.Based on the training set of 14 compounds,the prediction model was established,which was further verified by the test set of 5 compounds with template molecule included.It is found that steric an...     

Copper-Catalyzed Enantioselective Reductive Aldol Reaction of α,β-Unsaturated Carboxylic Acids to Alkyl Aryl Ketones: Silanes as Activator and Transient Protecting Group

The first enantioselective reductive aldol reaction of unprotected α,β-unsaturated carboxylic acids was developed by employing a copper/bisphosphine catalyst. The reaction features in situ protection and activation of an α,β-unsaturated carboxylic acid by a hydrosilane. The copper enolate formed in situ reacts with an alkyl aryl ketone to afford the β-hydroxy carboxylic acid with excellent enantioselectivity (up to 99 % ee). The corresponding gram-scale reaction with a low catalyst loading and the derivatization of the β-hydroxy carboxylic acids highlight the practicality of this transformation.     

Conjugate Addition of Alkyllithium Reagents to α,β-Unsaturated N,N',N'-Trimethylhydrazides

The site of nucleophilic attack by an alkyllithium reagent upon an α,β-unsaturated carbonyl compound is governed by, among other factors, the nature of the group attached to the carbonyl.¹ Thus the amount of carbonyl addition decreases in favor of conjugate addition for the α,β-unsaturated series: aldehyde, ketone, ester, amide. We wish to report that α,β-unsaturated carboxylic acid trimethylhydrazides, which have an exceptionally unreactive carbonyl group², undergo exclusive conjugate addition with simple alkyllithium reagents.³ Furthermore, the derived hydrazide lithium enolates can be transformed in convenient and useful ways.     

Regioselective copper-mediated synthesis of thieno[2,3-c]pyrane-7-one, indolo[2,3-c]pyrane-1-one, and indolo[3,2-c]pyrane-1-one

In the presence of copper(I) iodide, heteroaromatic β-iodo-α,β-unsaturated carboxylic acid systems opposed to terminal alkyne afford selectively 6-endo-dig cyclization products via a tandem coupling oxacyclization reaction.     

Stereoselectivity of the Diels-Alder Reaction of (E)-γ-Oxo-α,β-Unsaturated Thioesters with Cyclopentadiene

The stereoselectivity of the Diels-Alder reaction of (E)-γ-oxo-α,β-unsaturated thioesters 3a-3d with cyclopentadiene is greatly enhanced in the presence of Lewis acids favoring the endo acyl isomers 4a-4d . In the absence of Lewis acid, Diels-Alder reaction of 3a-3d with cyclopentadiene at 25 °C gave two adducts 4a-4d and 5a-5d in a ratio of 1:1 respectively. In the presence of Lewis acids, Diels-Alder reaction of 3a-3d with cyclopentadiene gave 4a-4d and 5a-5d in ratios of 75-94:25-6 respectively. The stereoelectivity was enhanced to ratios of 95-98:5-2 with lowering the reaction temperature. The stereochemistry of the cycloadducts 4 and 5 was confirmed by iodocyclization. Reaction of the endo-thioester 5c with I₂ in aqueous THF at 0 °C gave the novel methylthio group rearranged product 6c in 80% yield, the first example of iodo-lactonization of endo-thioesters. Reaction of the endo-acyl isomer 4b with I₂ under the same reaction conditions gave an isomeric mixture of 7b and 8b in 1:2 ratio. The stereochemistry of the thioester group in 8b was proved by X-ray single-crystal analysis. The solvent effect on the endo selectivity of (Z)-γ-oxo-α,β-unsaturated thioester 2b was also examined.     

Rh-catalyzed asymmetric hydrogenation using a furanoside monophosphite second-generation ligand library: scope and limitations

The ligand design of one of the most successful monophosphite ligand classes in Rh-catalyzed hydrogenation was expanded upon by introducing several substituents at the C-3 position of the furanoside backbone. A small but structurally important library of monophosphite ligands was developed by changing the substituents at the C-3 position of the furanoside backbone and the substituents/configurations at the biaryl phosphite group. These new furanoside monophosphite ligands were evaluated in the Rh-catalyzed asymmetric hydrogenation of α,β-unsaturated carboxylic acid derivatives and enamides. The results show that the effect of introducing a substituent at the C-3 position of the furanoside backbone on the enantioselectivity depends not only on the configuration at the C-3 position of the furanoside backbone and the binaphthyl group but also on the substrate. Thus, the new ligands afforded high to excellent enantioselectivities in the reduction of carboxylic acid derivatives (ee’s up to >99.9%) and moderate ee’s (up to 67%) in the hydrogenation of enamides.